KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Amortization of Deferred Charges (2016 - 2025)

Chemed (CHE) has 14 years of Amortization of Deferred Charges data on record, last reported at $80000.0 in Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges changed 0.0% year-over-year to $80000.0; the TTM value through Dec 2025 reached $321000.0, changed 0.0%, while the annual FY2025 figure was $321000.0, 0.0% changed from the prior year.
  • Amortization of Deferred Charges reached $80000.0 in Q4 2025 per CHE's latest filing, down from $81000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $325000.0 in Q2 2023 and bottomed at $76000.0 in Q1 2021.
  • Average Amortization of Deferred Charges over 5 years is $93500.0, with a median of $80000.0 recorded in 2023.
  • Peak YoY movement for Amortization of Deferred Charges: skyrocketed 322.08% in 2023, then plummeted 75.38% in 2024.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $77000.0 in 2021, then grew by 23.38% to $95000.0 in 2022, then dropped by 15.79% to $80000.0 in 2023, then changed by 0.0% to $80000.0 in 2024, then changed by 0.0% to $80000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization of Deferred Charges were $80000.0 in Q4 2025, $81000.0 in Q3 2025, and $80000.0 in Q2 2025.